CareMax Reports Third Quarter 2023 Results

Go back to CareMax Reports Third Quarter 2023 Results

CareMax (CMAX) cut as Piper Sandler 'cannot continue to recommend the stock'

November 10, 2023 12:10 PM EST

Piper Sandler analyst Jessica Tassan downgraded shares of CareMax (NASDAQ: CMAX) to Neutral from Overweight in a note to clients Friday, lowering the stock price target to $2 per share.

The analyst told investors that CMAX is taking a "justifiably cautious approach to... More